1. Home
  2. LCUT vs ENLV Comparison

LCUT vs ENLV Comparison

Compare LCUT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$8.88

Market Cap

201.8M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.72

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
ENLV
Founded
1945
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.8M
196.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
LCUT
ENLV
Price
$8.88
$0.72
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$5.00
$20.00
AVG Volume (30 Days)
180.7K
418.0K
Earning Date
05-07-2026
05-29-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$0.66
52 Week High
$9.80
$2.10

Technical Indicators

Market Signals
Indicator
LCUT
ENLV
Relative Strength Index (RSI) 58.69 39.84
Support Level $3.44 $0.66
Resistance Level $9.80 $1.23
Average True Range (ATR) 0.81 0.06
MACD 0.04 0.01
Stochastic Oscillator 65.23 20.89

Price Performance

Historical Comparison
LCUT
ENLV

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: